Framework of actions to contain carbapenemase-producing Enterobacterales

  09 January 2020

This framework focuses on carbapenemase-producing Enterobacterales
(CPE) because these organisms spread rapidly in healthcare settings and
leading to poor clinical outcomes because of limited therapeutic options.

The increased incidence of CPE has significant cost and operational implications for healthcare providers.

Unless action is taken, learning from experiences elsewhere in the world,
rapid spread of CPE will pose an ever-increasing threat to public health and
medical treatment pathways in the UK.

The framework sets out a range of measures, that if implemented well, will
help health and social care providers minimise the impact of CPE. These
include:

  • active patient admission screening of risk groups
  • rapid detection of patients colonised or infected with CPE to enable
    spread, with appropriate surveillance systems to capture this
  • prompt recognition of outbreaks and clusters to enable effective
    management
  • consistent implementation of infection prevention and control
    practices
  • minimisation of CPE reservoirs by effective environmental cleaning
    and decontamination
  • antimicrobial stewardship programmes to minimise inappropriate use
    of broad spectrum antibiotics, including carbapenems
  • optimised laboratory methods to detect carbapenemase producing
    bacteria
  • organisational ownership to support the implementation of this
    framework.

This document recognises that the evidence base for some
recommendations is limited and that local risk assessment is important for
building a local CPE policy that can be implemented based on the
Framework.

Author(s): Public Health England
Effective Surveillance   Healthy Patients  
Back


Display your AMR technology / product:

Global AMR Technologies Database

  • Preventive – Diagnostic – Antimicrobial technologies
  • Academia – Research Institutes – Start ups – SMEs – Multinationals
  • Early research <-> near market (max 5)
  • Global reach for funding / co-development / licensing
  • No costs (until year end 2019)

Festive Launch Database 19 Nov Symposium Dinner ‘Emerging Antimicrobials and Diagnostics in AMR 2019
Click to join the Symposium Dinner (to join the Symposium separate registration obligatory)

Display your technology >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!